Article
- The EMBO Journal (2006) 25, 1997 - 2006
- doi:10.1038/sj.emboj.7601062
Published online: 13 April 2006
Subject Categories:
An aging pathway controls the TrkA to p75NTR receptor switch and amyloid 
-peptide generation
Claudio Costantini1, Heidi Scrable2 and Luigi Puglielli1
- Department of Medicine, University of Wisconsin-Madison, Veterans Administration Hospital (GRECC 11G), Madison, WI, USA
- Department of Neuroscience, University of Virginia, Charlottesville, VA, USA
Correspondence to:
Luigi Puglielli, Department of Medicine, University of Wisconsin-Madison, VAH-GRECC 11G, 2500 Overlook Terrace, Madison, WI 53705, USA. Tel.: +1 608 2561901 ext. 11569; Fax: +1 608 2807291; E-mail: lp1@medicine.wisc.edu
Received 9 December 2005; Accepted 3 March 2006
Abstract
Aging of the brain is characterized by marked changes in the expression levels of the neurotrophin receptors, TrkA and p75NTR. An expression pattern in which TrkA predominates in younger animals switches to one in which p75NTR predominates in older animals. This TrkA-to-p75NTR switch is accompanied by activation of the second messenger ceramide, stabilization of 
-site amyloid precursor protein-cleaving enzyme-1 (BACE1), and increased production of amyloid -peptide (A). Here, we show that the insulin-like growth factor-1 receptor (IGF1-R), the common regulator of lifespan and age-related events in many different organisms, is responsible for the TrkA-to-p75NTR switch in both human neuroblastoma cell lines and primary neurons from mouse brain. The signaling pathway that controls the level of TrkA and p75NTR downstream of the IGF1-R requires IRS2, PIP3/Akt, and is under the control of PTEN and p44, the short isoform of p53. We also show that hyperactivation of IGF1-R signaling in p44 transgenic animals, which show an accelerated form of aging, is characterized by early TrkA-to-p75NTR switch and increased production of A in the brain.
Keywords:
- Alzheimer's disease,
- amyloid -peptide,
- ceramide,
- IGF1-R,
- p75NTR
